Kingsley Capital Partners
167-169 Great Portland Street, 5th Floor, London, England, W1W 5PF, United Kingdom
Overview
Kingsley Capital Partners is a private equity and venture capital firm backed by family offices and institutional investors. The company invests significant resources in researching growing markets, working with management teams to generate strong risk-adjusted returns. The company's heritage and close relationship with family offices and entrepreneurs from multiple industries is an essential resource for partner companies. Kingsley Capital Partners was founded in 2013 and is headquartered in London, United Kingdom.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 4
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Oxford Cannabinoid Technologies
Led · Equity · Mar 2017
Oxford Cannabinoid Technologies was established by Kingsley Capital Partners to finance a £10m research programme at Oxford University into medical cannabis. The programme will support eight university scientists investigating medical applications across pain, cancer and inflammatory disease. The company's core role is sponsoring laboratory research aimed at developing cannabinoid-based therapies. Funding is provided as venture capital from Kingsley, which set up the company to underwrite the work. The initiative positions the company as a research sponsor and potential developer of therapeutic candidates in partnership with Oxford. Kingsley is described in the article as a private equity business based in London and its managing partner, Neil Mahapatra, framed the project as targeting innovative therapies to help millions of patients.